Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

GLOBAL WIDGET LLC

US Class III Ongoing · initiated 2024-06-25

Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.

GLOBAL WIDGET LLC

US Class III Ongoing · initiated 2024-06-25

Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.

Amerisource Health Services LLC

US Class I Ongoing · initiated 2024-06-25

Failed Dissolution Specifications

JAMP-Doxazosin 4 mg

Canada Type II Ongoing · initiated 2024-06-25

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Zydus Pharmaceuticals (USA) Inc

US Class II Terminated · initiated 2024-06-21

Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.

A-S Medication Solutions LLC

US Class I Terminated · initiated 2024-06-21

Labeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets…

Fresenius Medical Care Holdings, Inc.

US Class II Ongoing · initiated 2024-06-18

This product is being recalled due to the tube weld failure presents itself as a slow leak and can be difficult to detect.

Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions

Canada Type I Ongoing · initiated 2024-06-14

Product quality. Immediately check your stock to see if your product is affected. If you have an affected product, do not use it, and immediately speak to your …

XQS nicotine pouches 4 & 6 mg

Canada Type II Ongoing · initiated 2024-06-13

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Zyn Nicotine Pouches 1.5 & 3mg

Canada Type II Ongoing · initiated 2024-06-12

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Brands International Corporation

US Class II Ongoing · initiated 2024-06-10

Microbial Contamination of Non-Sterile Products: confirmed presence of mold contamination

Taisho Pharmaceutical Pabron Gold A (Granules)

Canada Type II Ongoing · initiated 2024-06-10

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

PMS-PIRFENIDONE 267 & 801 mg

Canada Type I Ongoing · initiated 2024-06-07

Product quality. Return the affected products to your local pharmacy for a replacement, and for proper disposal. If you are unsure whether your product is affec…

Mint-Betahistine 8, 16 & 24mg

Canada Type I Ongoing · initiated 2024-06-06

Product quality. Return the affected products to your local pharmacy for a replacement, and for proper disposal. If you are unsure whether your product is affec…

Homeocare Laboratories, Inc.

US Class II Terminated · initiated 2024-06-05

Microbial Contamination of Non-Sterile Products: presence of Terribacillus species organism

Homeocare Laboratories, Inc.

US Class I Terminated · initiated 2024-06-05

Microbial Contamination of Non-Sterile Products: multiple Bacillus species organisms

Octaplasma solution

Canada Type III Ongoing · initiated 2024-06-03

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Jamp Digoxin tablet

Canada Type I Ongoing · initiated 2024-06-03

Product quality. Return your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take yo…

Washington Homeopathic Products, Inc.

US Class III Terminated · initiated 2024-05-31

Labeling: Label Mix-up: Some bottles of Ferrum Phosphoricum 200C were incorrectly labeled as Ferrum Metallicum 200C.

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2024-05-30

CGMP Deviations

Glenmark Pharmaceuticals Inc., USA

US Class I Ongoing · initiated 2024-05-30

Failed Dissolution Specifications

Glenmark Pharmaceuticals Inc., USA

US Class I Ongoing · initiated 2024-05-30

Failed Dissolution Specifications

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2024-05-30

CGMP Deviations

Extra Strength Heartburn Relief

Canada Type II Ongoing · initiated 2024-05-29

Contamination. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health conc…

Probiotic antibiotic support capsule

Canada Type II Ongoing · initiated 2024-05-27

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…